What is the effect of MUSE on women?
VIVUS recommends that suitable contraception be used for patients with partners of childbearing potential and that a condom should be used with partners who are already pregnant. The most common drug-drug related adverse event reported by female partners during placebo-controlled clinical studies was vaginal burning/itching, reported by 5.8% of partners of patients on active vs. 0.8% of partners of patients on placebo.
